amphetamine has been researched along with lisdexamfetamine dimesylate in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 10 (47.62) | 2.80 |
| Authors | Studies |
|---|---|
| Biederman, J; Boellner, SW; Childress, A; Krishnan, S; Lopez, FA; Zhang, Y | 1 |
| Buckwalter, M; Ermer, JC; Haffey, MB; Homolka, R; Lasseter, KC; Martin, P; Zhang, P | 1 |
| Harris, NS; Pitman, JT | 1 |
| Gosden, J; Heal, DJ; Nutt, DJ; Smith, SL | 1 |
| Gosden, J; Heal, D; Hutson, PH; Kulkarni, RS; Love, PL; Rowley, HL; Slater, N; Wang, Y | 1 |
| Lachaine, J; Mathurin, K; Sikirica, V | 1 |
| Ermer, JC; Frick, G; Pennick, M | 1 |
| Barreto, F; Carlos, G; Comiran, E; Fröehlich, PE; Limberger, RP; Meneghini, LZ | 1 |
| Helson, T; Keshen, A | 1 |
| Baumgartner, MR; Binz, TM; Dolder, PC; Kraemer, T; Liechti, ME; Steuer, AE; Strajhar, P; Williner, E | 1 |
| Locatelli, I; Lukić, P; Stuhec, M | 1 |
| Colpo, GD; John, V; Rocha, NP; Sassi, KLM; Teixeira, AL | 1 |
| Brink, P; Nielsen, J; Rohde, C; Østergaard, SD | 1 |
| Arcadepani, FB; Bisaga, A; Fidalgo, TM; Gerra, G; Levin, FR; Tardelli, VS | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Barreto, F; Carlos, G; Comiran, E; Fröehlich, PE; Limberger, RP; Pechanksy, F | 1 |
| Fekete, S; Gerlach, M; Högger, P; Romanos, M; Wohkittel, C | 1 |
| Ahlner, J; Chermá, MD; Johansson, A; Jönsson, AK; Nilsson, GH | 1 |
| Smith, CR; Swortwood, MJ | 1 |
| Iwase, H; Makino, Y; Namera, A; Noritake, K; Saka, K; Torimitsu, S; Yamaguchi, R | 1 |
| Surman, CBH; Walsh, DM | 1 |
7 review(s) available for amphetamine and lisdexamfetamine dimesylate
| Article | Year |
|---|---|
Amphetamine, past and present--a pharmacological and clinical perspective.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Drug Design; Humans; Lisdexamfetamine Dimesylate; Narcolepsy; Prodrugs | 2013 |
Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy.
Topics: Administration, Oral; Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Delivery Systems; Humans; Lisdexamfetamine Dimesylate; Male; Prodrugs; Treatment Outcome | 2016 |
Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Salts; Treatment Outcome | 2019 |
Amphetamine Use in the Elderly: A Systematic Review of the Literature.
Topics: Aged; Amphetamine; Dementia; Depressive Disorder, Major; Humans; Lisdexamfetamine Dimesylate; Methylphenidate | 2020 |
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Topics: Amphetamine; Central Nervous System Stimulants; Cocaine; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Prescription Drugs; Randomized Controlled Trials as Topic; Substance-Related Disorders; Treatment Outcome | 2020 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Executive Function; Humans; Lisdexamfetamine Dimesylate | 2023 |
2 trial(s) available for amphetamine and lisdexamfetamine dimesylate
| Article | Year |
|---|---|
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2007 |
Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.
Topics: Adult; Amphetamine; Area Under Curve; Cross-Over Studies; Delayed-Action Preparations; Dextroamphetamine; Drug Administration Schedule; Female; Humans; Lisdexamfetamine Dimesylate; Male; Medication Therapy Management; Metabolic Clearance Rate; Middle Aged; Omeprazole; Proton Pump Inhibitors; Young Adult | 2009 |
12 other study(ies) available for amphetamine and lisdexamfetamine dimesylate
| Article | Year |
|---|---|
Possible association with amphetamine usage and development of high altitude pulmonary edema.
Topics: Altitude Sickness; Amphetamine; Attention Deficit Disorder with Hyperactivity; Dextroamphetamine; Humans; Hypertension, Pulmonary; Lisdexamfetamine Dimesylate; Male; Middle Aged | 2012 |
The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a D-amphetamine cue.
Topics: Amphetamine; Analysis of Variance; Animals; Benzodiazepines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corpus Striatum; Cues; Dopamine; Dopamine Antagonists; Generalization, Stimulus; Limbic System; Lisdexamfetamine Dimesylate; Male; Olanzapine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tandem Mass Spectrometry; Time Factors | 2016 |
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Drug Therapy, Combination; Female; Guanfacine; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Male; Markov Chains; Methylphenidate; Ontario; Quality-Adjusted Life Years | 2016 |
Method validation and determination of lisdexamfetamine and amphetamine in oral fluid, plasma and urine by LC-MS/MS.
Topics: Amphetamine; Chromatography, Liquid; Clinical Chemistry Tests; Humans; Lisdexamfetamine Dimesylate; Reproducibility of Results; Saliva; Tandem Mass Spectrometry | 2017 |
Preliminary Evidence for the Off-Label Treatment of Bulimia Nervosa With Psychostimulants: Six Case Reports.
Topics: Adult; Amphetamine; Bulimia Nervosa; Delayed-Action Preparations; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Retrospective Studies; Young Adult | 2017 |
Chiral analysis of amphetamines in hair by liquid chromatography-tandem mass spectrometry: compliance-monitoring of attention deficit hyperactivity disorder (ADHD) patients under Elvanse® therapy and identification after controlled low-dose application.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Chromatography, High Pressure Liquid; Forensic Toxicology; Hair; Humans; Illicit Drugs; Lisdexamfetamine Dimesylate; Retrospective Studies; Stereoisomerism | 2018 |
The use of stimulants in depression: Results from a self-controlled register study.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Denmark; Depression; Dextroamphetamine; Drug Prescriptions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Registries; Suicide, Attempted | 2020 |
Lisdexamfetamine and amphetamine pharmacokinetics in oral fluid, plasma, and urine after controlled oral administration of lisdexamfetamine.
Topics: Administration, Oral; Adult; Amphetamine; Chromatography, Liquid; Humans; Lisdexamfetamine Dimesylate; Male; Saliva; Tandem Mass Spectrometry; Young Adult | 2021 |
Relationship Between Amphetamine Concentrations in Saliva and Serum in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Drug Monitoring; Female; Humans; Lisdexamfetamine Dimesylate; Male; Saliva; Serum | 2021 |
Use of Lisdexamfetamine or Amphetamine? Interpretation of Chiral Amphetamine Analyses.
Topics: Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Sweden | 2022 |
Analysis of methylphenidate, ethylphenidate, lisdexamfetamine, and amphetamine in oral fluid by liquid chromatography-tandem mass spectrometry.
Topics: Adolescent; Amphetamine; Child; Chromatography, Liquid; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Tandem Mass Spectrometry | 2022 |
Detection of lisdexamfetamine and its metabolite d-amphetamine in urine and gastric contents collected from a cadaver at forensic autopsy.
Topics: Amphetamine; Autopsy; Cadaver; Chromatography, Liquid; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Prodrugs; Tandem Mass Spectrometry | 2023 |